Results 21 to 30 of about 1,009 (151)
Blastische plasmazytoide dendritische Zellneoplasie (BPDCN)
Die Dermatologie, 2023 ZusammenfassungDie blastische plasmazytoide dendritische Zellneoplasie ist eine seltene hämatologische Neoplasie, die aus Vorläuferzellen der plasmazytoiden dendritischen Zellen entsteht und durch disseminierte, erythematöse bis bläulich-livide Plaques oder Nodi gekennzeichnet ist.
Nguyen, Katrin +3 more
openaire +1 more source
Haematologica, 2020 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic neoplasm whose immunophenotype remains incompletely characterized, particularly in terms of distinction from reactive plasmacytoid dendritic cells (PDCs).
Wei Wang +10 more
doaj +1 more source
Primary blastic plasmacytoid dendritic cell neoplasm: a US population-based study
Frontiers in Oncology, 2023 BackgroundBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and poorly understood hematopoietic malignancy. This study aimed to investigate the clinical characteristics and prognostic factors in patients with primary BPDCN.MethodsPatients ...
Lifang Huang, Fan Wang
doaj +1 more source
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity [PDF]
BMJ Case Reports, 2016 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive haematological malignancy in the elderly, with a high frequency of cutaneous and bone marrow involvement and poor prognosis. We report a case of BPDCN with classic presentation and discuss its treatment and the value of different investigation tools used in diagnosis and ...
Ming Sheng, Lim +2 more
openaire +2 more sources
Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases [PDF]
Iranian Journal of Medical Sciences, 2019 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here,
Akbar Safaei +4 more
doaj +1 more source
Blastic plasmacytoid dendritic cell neoplasm complicated with acute myeloid leukemia: a case report [PDF]
Xin yixue, 2023 Blastic plasmacytoid dendritic cell neoplasm （BPDCN） complicated with acute myeloid leukemia （AML） is a rare disease. In this article， we reported the diagnosis and treatment of one patient of BPDCN complicated with AML who presented with fever as the ...
Kong Lihua, Qin Lili, Feng Anhua, Liu Zhenzhen, Tang Na, Zang Jikang, Wang Haiying
doaj +1 more source
Leukemia Research Reports, 2022 Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare type of leukemia in children, Although BPDCN is a chemo-sensitive tumor, the relapse rate is very high.
Dima Abla +4 more
doaj +1 more source
An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor
Case Reports in Pathology, 2019 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells that represent less than 1% of hematological malignancies.
Daniel M. Pak, Maria S. Tretiakova
doaj +1 more source
eJHaem, 2023 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is recurrently mutated in epigenetic pathway genes. We studied the myeloid‐related genetic mutations in a cohort of five patients with BPDCN and one paired relapse case at our institution and ...
Xi Zhang +3 more
doaj +1 more source
Blastic plasmacytoid dendritic cell neoplasm of the uterus [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2020 Introduction. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and very aggressive hematological malignancy derived from precursor of the plasmacytoid dendritic cell.
Đurđević Predrag +8 more
doaj +1 more source